11/24
09:00 am
aztr
Azitra, Inc. Announces Pricing of $1.5 Million Private Placement Priced At a Premium To Market Under NYSE Rules
Medium
Report
Azitra, Inc. Announces Pricing of $1.5 Million Private Placement Priced At a Premium To Market Under NYSE Rules
11/13
04:31 am
aztr
Azitra reports Q3 results [Seeking Alpha]
High
Report
Azitra reports Q3 results [Seeking Alpha]
11/12
06:03 pm
aztr
Azitra, Inc. Announces Q3 2025 Results and Provides Business Updates [Yahoo! Finance]
High
Report
Azitra, Inc. Announces Q3 2025 Results and Provides Business Updates [Yahoo! Finance]
11/12
05:15 pm
aztr
Azitra, Inc. Announces Q3 2025 Results and Provides Business Updates
High
Report
Azitra, Inc. Announces Q3 2025 Results and Provides Business Updates
11/7
06:00 am
aztr
Azitra, Inc. Addresses False Report Regarding Sale of Securities
Medium
Report
Azitra, Inc. Addresses False Report Regarding Sale of Securities
10/20
08:02 am
aztr
Azitra, Inc. Announces Positive Preclinical Data for ATR-01 Program, Designed to Treat Ichthyosis Vulgaris
High
Report
Azitra, Inc. Announces Positive Preclinical Data for ATR-01 Program, Designed to Treat Ichthyosis Vulgaris
10/15
04:28 pm
aztr
Azitra to Participate in Dermatologic Rare Disease Panel at Maxim Growth Summit [Yahoo! Finance]
Low
Report
Azitra to Participate in Dermatologic Rare Disease Panel at Maxim Growth Summit [Yahoo! Finance]
10/15
04:05 pm
aztr
Azitra to Participate in Dermatologic Rare Disease Panel at Maxim Growth Summit
Low
Report
Azitra to Participate in Dermatologic Rare Disease Panel at Maxim Growth Summit
10/3
05:18 pm
aztr
Azitra Receives Notice of Non-Compliance from NYSE American [Yahoo! Finance]
Low
Report
Azitra Receives Notice of Non-Compliance from NYSE American [Yahoo! Finance]
10/3
04:45 pm
aztr
Azitra Receives Notice of Non-Compliance from NYSE American
Low
Report
Azitra Receives Notice of Non-Compliance from NYSE American
9/30
06:22 am
aztr
EGFR Inhibitors Induced Skin Disorders Market Research 2025-2035: Targeted Therapies, Biologics and Personalized Medicine Drive Growth with Biomarker Advances [Yahoo! Finance]
Low
Report
EGFR Inhibitors Induced Skin Disorders Market Research 2025-2035: Targeted Therapies, Biologics and Personalized Medicine Drive Growth with Biomarker Advances [Yahoo! Finance]